Related Experiment Video
Updated: Jun 13, 2025

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015
Hematopoietic stem cell gene therapy to halt neurodegeneration
1Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Women and Child's Health, University of Padova and Padova University Hospital, Padova, Italy.
Abstract:
Microglia play fundamental roles in multiple pathological primary and secondary processes affecting the central nervous system that ultimately result in neurodegeneration and for this reason they are considered as a key therapeutic target in several neurodegenerative diseases. Microglia-targeted therapies are directed at either restoring or modulating microglia function, to redirect their functional features toward neuroprotection. Among these strategies, hematopoietic stem cell gene therapy have proven to be endowed with a unique potential for replacing diseased microglia with engineered, transplant progeny cells that can integrate and exert relevant beneficial effects in the central nervous system of patients affected by inherited and acquired neurodegenerative conditions.
Insights
Hematopoietic stem cell gene therapy offers a novel approach to neurodegenerative diseases by replacing diseased microglia with beneficial, engineered cells. This microglia-targeted therapy aims to restore central nervous system function and promote neuroprotection.
Area of Science:
- Neuroscience
- Immunology
- Gene Therapy
Background:
- Microglia are crucial cells in the central nervous system (CNS) involved in neurodegenerative diseases.
- Dysfunctional microglia contribute to neurodegeneration, making them a key therapeutic target.
- Current microglia-targeted therapies aim to restore or modulate their function towards neuroprotection.
Purpose of the Study:
- To explore the potential of hematopoietic stem cell gene therapy for treating neurodegenerative conditions.
- To investigate the capacity of engineered stem cells to replace and improve microglia function in the CNS.
Main Methods:
- Utilizing hematopoietic stem cell gene therapy to engineer transplant progeny cells.
- Administering engineered cells to integrate into the CNS and replace diseased microglia.
Main Results:
- Engineered stem cells successfully integrated into the CNS.
- Transplanted cells demonstrated the potential to replace diseased microglia and exert beneficial effects.
- This approach shows promise for treating inherited and acquired neurodegenerative conditions.
Conclusions:
- Hematopoietic stem cell gene therapy presents a unique and effective strategy for microglia replacement in neurodegenerative diseases.
- This therapy holds significant potential for restoring CNS function and achieving neuroprotection in affected patients.
Related Concept Videos
Gene Therapy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
iPS Cell Differentiation
Multipotency of Hematopoietic Stem Cells
Regulation of Hematopoietic Stem Cells
Stem Cell Culture

